NCT00244439View on ClinicalTrials.gov

Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions
Lice Infestations
Interventions
DRUG

MALG

30 minute application

DRUG

Ovide (malathion) lotion 0.05%

8-12 hour application

DRUG

Permethrin 1%

10 minute application

Trial Locations (6)

Unknown

Investigator Site, Scottsdale

Investigator Site, Miami

Investigator Site, St. Petersburg

Investigator Site, West Palm Beach

Investigator Site, New York

Investigator Site, Miamiville

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT00244439 - Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice | Biotech Hunter | Biotech Hunter